false
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Hamburger Menu
Catalog
Partner Programs
Society Store
Clinical Guidelines
Help & Tutorials
Catalog
Denosumab Discontinuation
Denosumab Discontinuation
Presentations/Presenters
Denosumab Discontinuation
Presenter:
Bente Langdahl, MD, PhD, DMSc (Aarhus University Hospital)
Relationship: Commercial Interest(s)
Advisory Board Member: Amgen Inc
Advisory Board Member: Other (fill in the blank below)
Advisory Board Member: UCB, Gedeon-Richter
Speaker: AstraZeneca
Speaker: Other (fill in the blank below)
Speaker: UCB, Gedeon-Richter, Astellas
Grant Recipient: Amgen Inc
Grant Recipient: Novo Nordisk
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
0.75 AMA PRA Category 1 Credit
×
Denosumab Discontinuation Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
EndoCareers
|
Contact Us
|
Privacy Policy
|
Terms of Use
CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036
202.971.3636 | 888.363.6274
×